Review of the symposium «Recommendations for the treatment of patients with frequent combination of gastrointestinal symptoms»

The article provides an overview of the reports of the satellite symposium «Recommendations for the treatment of patients with frequent combination of gastrointestinal symptoms», which took place within the framework of the 116th International Session of the National School of Gastroenterology and Hepatology of the Russian Gastroenterological Association. The speakers discussed the approaches to the management of patients with a typical, frequent combination of gastrointestinal symptoms using specific examples from their clinical practice. Special emphasis in the reports was made on the role of microbiota in maintaining and strengthening the physical and mental health of a person, the negative consequences of dysbiotic changes in the gastrointestinal tract and the use of pro- and prebiotics to correct these changes. 

1. Thabane M., Kottachchi D. T., Marshall J. K. Systematic review and metaanalysis: the incidence and prognosis of post-infectious irritable bowel syndrome // Alimentary pharmacology & therapeutics. 2007. Т. 26. № 4. С. 535–544.

2. Borgaonkar M. R., Ford D. C., Marshall J. K. et al. The incidence of irritable bowel syndrome among community subjects with previous acute enteric infection // Dig Dis Sci. 2006. № 51. Р. 1062–1032.

3. Parry S. D., Barton J. R., Welfare M. R. Factors associated with the development of post- infectious functional gastrointestinal dis-eases: does smoking play a role? // Eur J Gastroenterol Hepatol. 2005. Vol. 17. № 10. Р. 1071–1075.

4. Simanenkov V. I., Lutayenko Ye. A. Diagnostika i terapiya postinfektsionnogo sindroma razdrazhennogo kishechnika [Diagnostics and therapy of post-infectious irritable bowel syndrome] Sonsilium medicum (gastroenterologiya). 2011. № 2. Pp. 42—48.

5. Primentel M. Review of rifaximin as a treatment for SIBO and IBS // Expert Opin Invest Drugs. 2009. V. 18. № 3. P. 349–358.

6. Rezaie A., Buresi M., Lembo A. et al. Hydrogen and methane-based breath testing in gastrointestinal disorders: The North American Consensus // Am. J. Gastroenterol. 2017. Vol. 112. № 5. P. 775–784.

7. Ivashkin V. T. i dr. Klinicheskiye rekomendatsii Rossiyskoy gastroenterologicheskoy assotsiatsii, Assotsiatsii koloproktologov Rossii po diagnostike i lecheniyu bol’nykh s sindromom razdrazhennogo kishechnika [Clinical guidelines of the Russian Gastroenterological Association, the Association of Coloproctologists of Russia for the diagnosis and treatment of patients with irritable bowel syndrome] Ros zhurn gastroenterol gepatol koloproktol. 2017. T. 27. № 5. Pp. 76–93.

8. Ivashkin V., Drapkina O., Poluektova Ye. et al. The Effect of a multi-strain probiotic on the symptoms and small intestinal bacterial overgrowth in constipationpredominant irritable bowel syndrome: a randomized, simple-blind, placebocontrolled trial // Am. J. Clin. Med. Res. 2015. Vol. 3. № 2. P. 18–23.

9. Tipikina M. Yu., Korniyenko Ye. A. Patogeneticheski obosnovannaya strategiya terapii sindroma razdrazhennogo kishechnika u detey [Pathogenetically substantiated strategy for the treatment of irritable bowel syndrome in children] Voprosy detskoy diyetologii. 2014. T. 12. №. 1. Pp. 22–27.

10. Honkura K., Tomata Y., Sugiyama K. et al. Defecation frequency and cardiovascular disease mortality in Japan: the Ohsaki cohort study // Atherosclerosis. 2016. Vol. 246. P. 251–256.

11. Shemerovskiy K. A. Khronofiziologicheskiye osobennosti gastroduodenal’noy mioelektricheskoy aktivnosti i evakuatornoy funktsii kishechnika. [Chronophysiological features of gastroduodenal myoelectric activity and evacuation function of the intestine.] Avtoref. diss. d.m.n. SPb, 2004.

12. Shemerovskiy K. A., Khronoenterografiya – monitoring okolosutochnogo ritma evakuatornoy funktsii kishechnika [Chronoenterography — monitoring of the circadian rhythm of the intestinal evacuation function] Byull. Eksper. Biol. i Med. 2002. T. 133, № 5, pp. 582–584.

13. Ivashkin V. T., Alekseyenko S. A., Kolesova T. A. i dr. Rezolyutsiya Ekspertnogo soveta, posvyashchennogo problemam diagnostiki i lecheniya funktsional’nykh zabolevaniy zheludochno-kishechnogo trakta [Resolution of the Expert Council dedicated to the problems of diagnosis and treatment of functional diseases of the gastrointestinal tract] // Rossiyskiy zhurnal gastroenterologii, gepatologii, koloproktologii. 2016. T. 26. № 4. P. 129–130.

14. Patil D. H. et al. Comparative modes of action of lactitol and lactulose in the treatment of hepatic encephalopathy // Gut. 1987. Т. 28. №. 3. С. 255–259.

15. Ardatskaya M. D. i dr. Kliniko-metabolicheskaya effektinost’ laktitola v terapii khronicheskogo zapora (rezul’taty neinterventsionnoy prospektivnoy nablyudatel’noy programmy «OSMOAID») [Clinical and metabolic efficacy of lactitol in the treatment of chronic constipation (results of the non-interventional prospective observational program «OSMOAID»)] Eksperimental’naya i klinicheskaya gastroenterologiya. 2018. №. 2 (150).

16. Zhuang M. et al. Abundance of Probiotics and Butyrate-Production Microbiome Manages Constipation via Short-Chain Fatty Acids Production and Hormones Secretion // Molecular Nutrition & Food Research. 2019. Т. 63. №. 23. С. 180–187.

17. Kucheryavyy Yu. A., Andreyev D. N., Cheremushkin S. V. Khronicheskiy zapor: aktual’nost’, problemy i sovremennyye vozmozhnosti lecheniya [Chronic constipation: relevance, problems and modern treatment options] // Consilium Medicum. 2017. T. 19. № 8. P. 121–130.

18. Maydeo A. Lactitol or lactulose in the treatment of chronic constipation: result of a systematic //Journal of the Indian Medical Association. 2010. Т. 108. №. 11. С. 789–792.

19. Irvine E. J. et al. Health-related quality of life in functional GI disorders: focus on constipation and resource utilization //The American journal of gastroenterology. – 2002. – Т. 97. – №. 8. – С. 1986-1993.

20. Drossman D. A. Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV // Gastroenterol. 2016; 150 (6): 1262–1279.

21. Ivashkin V. T. i dr. Klinicheskiye rekomendatsii Rossiyskoy gastroenterologicheskoy assotsiatsii po diagnostike i lecheniyu diskinezii zhelchevyvodyashchikh putey [Clinical guidelines of the Russian Gastroenterological Association for the diagnosis and treatment of biliary dyskinesia] Rossiyskiy zhurnal gastroenterologii, gepatologii, koloproktologii. 2018. T. 28. №. 3. Pp. 63–80.

22. Cotton P. B. et al. Gallbladder and sphincter of Oddi disorders // Gastroenterology. 2016. Т. 150. №. 6. С. 1420–1429.

23. Ivashkin V. T., Pavlov Ch. S., Popova I. R., Shul’pekova Yu. O. Trimebutina maleata v lechenii funktsional’nykh biliarnykh rasstroystv: rezul’taty nablyudatel’nogo issledovaniya TRIBUNE [Trimebutine maleate in the treatment of functional biliary disorders: the results of the observational study TRIBUNE] // Meditsinskiy sovet. 2018. № 21. P. 117–125.

24. Dixon M. F., O’Connor H. J., Axon A. T., Johnston D. Reflux gastritis: distinct histopathological entity? // L Clin Pathol. 1996; 39 (5): 524–530.

25. Matsuhisa T., Tsukui Т. Relation between reflux of bile acids into the stomach and gastric mucosal atrophy, intestinal metaplasia in biopsy specimens // J Clin Biochem Nutr. 2012; 50 (3): 217–221.

26. McCafferty D. F., Woolfson A. D. A comparative assessment of a new antacid formulation based on magaldrate //Journal of Clinical Pharmacy and Therapeutics. – 1983. – Т. 8. – №. 4. – С. 349-355.